Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;40(1):26-35.
doi: 10.1007/s11096-017-0574-8. Epub 2017 Dec 6.

Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients

Affiliations

Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients

Saurav Ghimire et al. Int J Clin Pharm. 2018 Feb.

Abstract

Background Medication nonadherence is a major problem in chronic kidney failure patients undergoing dialysis. Pharmacists play a vital role in improving medication-related patient outcomes, reducing drug-related problems, and improving medication adherence. However, little is known about how pharmacists assess medication adherence in dialysis patients. Objective To measure pharmacists' perceptions, current practices, and barriers to assessing adherence in dialysis patients. Setting Australian renal-specialised pharmacists. Method An online survey was conducted between March and May 2016. Survey included five psychometric scales measuring perceived prevalence, contributors, effective methods, barriers, and confidence to assess adherence on a 10-point Likert scale (1 = strongly disagree; 10 = strongly agree). Current practices were identified using a 4-point graded response (1 = do not practice; 4 = practice for all).

Main outcome measure: Perception scores, scale reliability, and responses to current practices questionnaire. Results 41 pharmacists completed the survey (response rate, 91.1%). The majority (91.9%, n = 34; median = 8.0) agreed patients were nonadherent to medication. Time constraints (43.8%, n = 14) and hospital support (31.3%, n = 10) were perceived as barriers to assessment. Objective blood monitoring was frequently used to determine nonadherence (57.1%, n = 16), whereas subjective interviews were rarely conducted (27.6%, n = 8). Though all pharmacists support the presence of dedicated pharmacist for assessing adherence (100.0%, n = 33), only 24.2% were actually performing this function. Conclusion Pharmacists were rarely assigned for adherence assessment in dialysis settings. Established self-report methods were under-utilised compared to objective methods. Future research should investigate the effectiveness of pharmacists' involvement in facilitating adherence promotion and early identification of medication-related issues in dialysis patients.

Keywords: Australia; Dialysis; Kidney failure, chronic; Medication adherence; Renal pharmacists.

PubMed Disclaimer

References

    1. PLoS Med. 2007 Oct 16;4(10):e297 - PubMed
    1. Am J Nephrol. 2016;43(5):318-24 - PubMed
    1. Am J Med. 2005 Dec;118(12):1414 - PubMed
    1. Int J Nurs Stud. 2008 Dec;45(12):1742-56 - PubMed
    1. Prog Transplant. 2011 Dec;21(4):322-31 - PubMed

LinkOut - more resources